Incyte
INCY

Incyte (INCY) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$150.00Aug 20, 2026
Canaccord GenuityInitiated CoverageBuy$152.00Aug 20, 2026
Piper SandlerMaintainedOverweight$130.00 from $110.00Aug 17, 2026
MizuhoMaintainedOutperform$137.00 from $121.00Aug 4, 2026
HC Wainwright & Co.MaintainedBuy$150.00Aug 3, 2026
Leerink PartnersMaintainedOutperform$155.00 from $131.00Aug 3, 2026
HC Wainwright & Co.MaintainedBuy$150.00 from $140.00Jul 29, 2026
BarclaysMaintainedOverweight$139.00 from $134.00Jul 29, 2026
GuggenheimMaintainedBuy$150.00 from $136.00Jul 29, 2026
BMO CapitalMaintainedMarket Perform$130.00 from $112.00Jul 29, 2026
RBC CapitalMaintainedSector Perform$109.00 from $99.00Jul 29, 2026
Morgan StanleyMaintainedEqual-Weight$104.00 from $103.00Jul 23, 2026
JP MorganMaintainedNeutral$110.00 from $105.00Jul 23, 2026
HC Wainwright & Co.MaintainedBuy$140.00Jul 21, 2026
BarclaysMaintainedOverweight$134.00 from $117.00Jul 14, 2026
BMO CapitalMaintainedMarket Perform$112.00 from $94.00Jul 13, 2026
RBC CapitalMaintainedSector Perform$99.00 from $95.00Jul 7, 2026
HC Wainwright & Co.MaintainedBuy$140.00Jun 29, 2026
UBSMaintainedNeutral$113.00 from $103.00Jun 26, 2026
HC Wainwright & Co.MaintainedBuy$140.00Jun 24, 2026

Frequently asked questions

  • What is the latest analyst rating on INCY?

    On Aug 20, 2026, HC Wainwright & Co. maintained Incyte at Buy with a price target of $150.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.